🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Provide pre-approval single patient Expanded Access (compassionate use) of ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05466578
Treatments Being Tested
A Phase 1, Open Label, Parallel-Cohort, Randomized, Fixed Sequence Study To...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-12
Trial ID
NCT03634345
Study B7451006 is a Phase 2b POC study which is planned to assess four PF 0...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2016-04
Trial ID
NCT02780167
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, single dose, open label stu...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-11-21
Trial ID
NCT03742336
Treatments Being Tested
This study will investigate the absorption, metabolism and excretion of 14C...
Status
Completed
Location
PRA Health Sciences
Start Date
2017-07-10
Trial ID
NCT03250039
Treatments Being Tested
This is a randomized, double blind, placebo controlled, parallel group, Pha...
Status
Completed
Location
Clinical Research Center of Alabama, LLC
Start Date
2019-02-18
Trial ID
NCT03796676
Treatments Being Tested
Part A * To measure and compare the amount of study drug in the blood afte...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2019-07-18
Trial ID
NCT04065633
This single- and multiple-ascending dose study is the first evaluation of P...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-05
Trial ID
NCT01835197
Treatments Being Tested
Study B7451005 is a Phase 2 study which will assess the efficacy and safety...
Status
Terminated
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2014-11
Trial ID
NCT02201524
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, multiple dose, open label s...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2019-01-23
Trial ID
NCT03806101
Treatments Being Tested